LeMaitre Vascular (NASDAQ:LMAT) Reaches New 52-Week Low - What's Next?

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as $88.85 and last traded at $90.74, with a volume of 163481 shares. The stock had previously closed at $92.60.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Lake Street Capital upped their target price on shares of LeMaitre Vascular from $105.00 to $110.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. Oppenheimer lowered LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Wells Fargo & Company assumed coverage on LeMaitre Vascular in a research note on Thursday, February 13th. They set an "equal weight" rating and a $95.00 target price on the stock. Finally, Barrington Research cut LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Five analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $98.14.

LeMaitre Vascular Stock Performance

The company has a market cap of $1.78 billion, a P/E ratio of 43.01, a P/E/G ratio of 2.22 and a beta of 0.89. The stock has a 50 day moving average price of $85.58 and a 200 day moving average price of $93.34.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.02). LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. The business had revenue of $59.87 million for the quarter, compared to the consensus estimate of $57.61 million. During the same quarter last year, the business posted $0.44 EPS. The business's revenue for the quarter was up 12.0% on a year-over-year basis. As a group, equities research analysts predict that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.

LeMaitre Vascular Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, May 15th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date is Thursday, May 15th. LeMaitre Vascular's payout ratio is 41.24%.

Insider Activity

In other LeMaitre Vascular news, insider Trent G. Kamke sold 2,009 shares of the business's stock in a transaction dated Wednesday, March 12th. The stock was sold at an average price of $82.12, for a total transaction of $164,979.08. Following the sale, the insider now owns 5,564 shares in the company, valued at approximately $456,915.68. The trade was a 26.53 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 10.79% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On LeMaitre Vascular

Large investors have recently made changes to their positions in the company. Segall Bryant & Hamill LLC raised its stake in LeMaitre Vascular by 29.4% during the 1st quarter. Segall Bryant & Hamill LLC now owns 76,460 shares of the medical instruments supplier's stock valued at $6,415,000 after purchasing an additional 17,354 shares during the period. Victory Capital Management Inc. raised its position in LeMaitre Vascular by 45.9% during the first quarter. Victory Capital Management Inc. now owns 79,871 shares of the medical instruments supplier's stock valued at $6,701,000 after buying an additional 25,133 shares during the period. Mutual of America Capital Management LLC lifted its stake in LeMaitre Vascular by 6.1% in the 1st quarter. Mutual of America Capital Management LLC now owns 35,331 shares of the medical instruments supplier's stock worth $2,964,000 after acquiring an additional 2,038 shares in the last quarter. Alps Advisors Inc. acquired a new stake in LeMaitre Vascular during the 1st quarter worth about $354,000. Finally, Linden Thomas Advisory Services LLC grew its stake in LeMaitre Vascular by 3.2% during the 1st quarter. Linden Thomas Advisory Services LLC now owns 35,591 shares of the medical instruments supplier's stock valued at $2,986,000 after acquiring an additional 1,109 shares in the last quarter. Institutional investors and hedge funds own 84.64% of the company's stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.